Carli D, Rondot F, Luca M, Campello A, Vallero S, Tirtei E
Cancers (Basel). 2024; 16(23).
PMID: 39682154
PMC: 11640037.
DOI: 10.3390/cancers16233967.
ONeill A, Ribeiro R, Pinto E, Clay M, Zambetti G, Orr B
Cancer Manag Res. 2024; 16:1141-1153.
PMID: 39263332
PMC: 11389717.
DOI: 10.2147/CMAR.S348725.
Briscik M, Dillies M, Dejean S
BMC Bioinformatics. 2023; 24(1):282.
PMID: 37438763
PMC: 10337068.
DOI: 10.1186/s12859-023-05404-y.
Relav L, Doghman-Bouguerra M, Ruggiero C, Muzzi J, Figueiredo B, Lalli E
Int J Mol Sci. 2023; 24(4).
PMID: 36835002
PMC: 9959402.
DOI: 10.3390/ijms24043585.
Fang C, Ye Y, Wang F, Shen Y, You Y
Intractable Rare Dis Res. 2022; 11(3):133-142.
PMID: 36200027
PMC: 9437998.
DOI: 10.5582/irdr.2022.01077.
Identification of Four Novel Prognostic Biomarkers and Construction of Two Nomograms in Adrenocortical Carcinoma: A Multi-Omics Data Study Bioinformatics and Machine Learning Methods.
Yi X, Wan Y, Cao W, Peng K, Li X, Liao W
Front Mol Biosci. 2022; 9:878073.
PMID: 35693556
PMC: 9174903.
DOI: 10.3389/fmolb.2022.878073.
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
Tamburello M, Altieri B, Sbiera I, Sigala S, Berruti A, Fassnacht M
Endocrine. 2022; 77(3):411-418.
PMID: 35583844
PMC: 9385797.
DOI: 10.1007/s12020-022-03074-z.
Distinct Murine Pancreatic Transcriptomic Signatures during Chronic Pancreatitis Recovery.
Zhang Y, Yang B, Davis J, Drake M, Younes M, Shen Q
Mediators Inflamm. 2021; 2021:5595464.
PMID: 34104113
PMC: 8158417.
DOI: 10.1155/2021/5595464.
Pathway Analysis of Renal Cell Carcinoma Genome-Wide Association Studies Identifies Novel Associations.
Purdue M, Song L, Scelo G, Houlston R, Wu X, Sakoda L
Cancer Epidemiol Biomarkers Prev. 2020; 29(10):2065-2069.
PMID: 32732251
PMC: 9438507.
DOI: 10.1158/1055-9965.EPI-20-0472.
Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma.
Xiao H, He W, Chen P, Xu D, Zeng G, Li Z
Front Endocrinol (Lausanne). 2019; 10:472.
PMID: 31354635
PMC: 6640086.
DOI: 10.3389/fendo.2019.00472.
TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors.
Passaia B, Dias M, Kremer J, Antonini S, de Almeida M, Fragoso M
Front Endocrinol (Lausanne). 2018; 9:38.
PMID: 29520253
PMC: 5827685.
DOI: 10.3389/fendo.2018.00038.
Common module analysis reveals prospective targets and mechanisms of pediatric adrenocortical adenoma and carcinoma.
Kulshrestha A, Suman S
Oncol Lett. 2018; 15(3):3267-3272.
PMID: 29435068
PMC: 5778872.
DOI: 10.3892/ol.2017.7646.
Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.
Pinto E, Rodriguez-Galindo C, Pounds S, Wang L, Clay M, Neale G
J Clin Oncol. 2017; 35(35):3956-3963.
PMID: 29058986
PMC: 5721229.
DOI: 10.1200/JCO.2017.74.2460.
GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior.
Pinheiro C, Granja S, Longatto-Filho A, Faria A, Fragoso M, Lovisolo S
Oncotarget. 2017; 8(38):63835-63845.
PMID: 28969033
PMC: 5609965.
DOI: 10.18632/oncotarget.19135.
Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.
Penny M, Finco I, Hammer G
Mol Cell Endocrinol. 2016; 445:42-54.
PMID: 27940298
PMC: 5508551.
DOI: 10.1016/j.mce.2016.12.005.
Network analysis reveals potential markers for pediatric adrenocortical carcinoma.
Kulshrestha A, Suman S, Ranjan R
Onco Targets Ther. 2016; 9:4569-81.
PMID: 27555782
PMC: 4968868.
DOI: 10.2147/OTT.S108485.
Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?.
Leccia F, Batisse-Lignier M, Sahut-Barnola I, Val P, Lefrancois-Martinez A, Martinez A
Front Endocrinol (Lausanne). 2016; 7:93.
PMID: 27471492
PMC: 4945639.
DOI: 10.3389/fendo.2016.00093.
Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study.
Pinto E, Rodriguez-Galindo C, Choi J, Pounds S, Liu Z, Neale G
Clin Cancer Res. 2016; 22(24):6247-6255.
PMID: 27307598
PMC: 5159323.
DOI: 10.1158/1078-0432.CCR-15-2738.
Novel targeted therapies in adrenocortical carcinoma.
Konda B, Kirschner L
Curr Opin Endocrinol Diabetes Obes. 2016; 23(3):233-41.
PMID: 27119750
PMC: 5011969.
DOI: 10.1097/MED.0000000000000247.
The challenge of developmental therapeutics for adrenocortical carcinoma.
Costa R, Carneiro B, Tavora F, Pai S, Kaplan J, Chae Y
Oncotarget. 2016; 7(29):46734-46749.
PMID: 27102148
PMC: 5216833.
DOI: 10.18632/oncotarget.8774.